Doctors at Harbor-UCLA are participating in a COVID-19 vaccine trial, and they're aiming to recruit people of color and members of other high-risk groups.
The first wave of coronavirus vaccines might be like a flu shot, experts say, curbing symptoms in some patients but not protecting them from COVID-19.
Enrolling a diverse group of patients will also help build trust in and uptake of a COVID-19 vaccine, Corado said. In aby The Associated Press-NORC Center for Public Affairs Research, just 25% of Blacks and 37% of Hispanics said they would definitely seek out the vaccine, compared with 56% of whites.
In July, the Harbor-UCLA vaccine team began holding weekly Zoom meetings with about 25 activists and clergy members to learn what people in their communities were saying about the vaccine, and to get tips on how to design educational materials for the trial.One member of the community council, HIV activist, noted that people frequently say on social media that the vaccine is designed to spread COVID-19 as part of a plot to get rid of black voters.
“It may seem far-fetched, but those are the conversations because we have an administration that has not shown itself to be trustworthy,” Morrison said. He noted that the first challenge Harbor-UCLA recruiters face is convincing community leaders, particularly clergy members, that the vaccine is safe. Church leaders worry they’ll be blamed for supporting the trial if the vaccine ends up making their congregants sick, he said.If done right, the trial could build trust in medical science while helping minorities help themselves — and the rest of us — find a way out of the current mess, Morrison said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
‘It’s been Covid, Covid, Covid’: Pro-Trump super PAC plans ad blitz on the economyAmericans are still grappling with a global pandemic that has claimed nearly 180,000 lives in the U.S. alone. But America First Action, the largest super PAC supporting President Donald Trump’s reelection, is about to go all-in on the economy.
Weiterlesen »
Coronavirus: AstraZeneca starts trial of COVID-19 antibody treatmentBritish drugmaker AstraZeneca has started early testing of an antibody-based treatment for the prevention and treatment of COVID-19, the company said on Tuesday.
Weiterlesen »
AstraZeneca starts trial of COVID-19 antibody treatmentBritish drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus.
Weiterlesen »
S&P 500, Nasdaq at all-time highs on COVID-19 treatment hopesThe S&P 500 and the Nasdaq scaled new heights on Monday, boosted by technology mega-caps and U.S. approval for the emergency use of blood plasma in treating COVID-19 patients.
Weiterlesen »
Will Trump Pressure the FDA to Approve an Unsafe Covid-19 Vaccine?The Food and Drug Administration authorized use of plasma to treat coronavirus patients — after the president alleged the “deep state, or whoever” is holding up Covid-19 treatments
Weiterlesen »
WHO says 172 countries engaging with global COVID-19 vaccine planSome 172 countries are engaging with the COVAX facility designed to ensure equitable access to COVID-19 vaccines, the World Health Organization said on Monday, but more funding is needed and countries need now to make binding commitments.
Weiterlesen »